Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SRL Inc.

Division of Miraca Holdings Inc.

Latest From SRL Inc.

Asia Deal Watch: Zogenix Partners Japanese Rights To Pediatric Epilepsy Therapy To Nippon Shinyaku

Nippon Shinyaku obtains rights to sell Dravet and Lennox-Gastaut syndrome drug Fintepla in its home market. Sun Pharma increases its ownership stake in Russia’s PJSC Biosintez.

Asia Pacific Commercial

Xoma Prepares for a Comeback

Despite the early-90s failure of its first product, an anti-sepsis monoclonal antibody, Xoma Corp. has persisted in developing pharmaceuticals for endotoxin-related disorders. The firm has no intention of letting past failings, like the lack of a rapid diagnostic, sink it twice. So it's doing deals with diagnostics companies, and talking up recent research about endotoxins.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Miraca Holdings Inc.
  • Senior Management
  • K. Fujita, MD, PhD, Pres. & CEO
    K. Kubota, Mgr., Product Planning
    H. Tukada, MD, PhD, Dir., R&D
  • Contact Info
  • SRL Inc.
    Phone: (81) 3 3344 6511
    Yasudakasai Tachikawa Bldg.
    Tokyo, 163